Seroxat

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Seroxat

What is Seroxat? (Paroxetine)

Property Description
Active ingredient Paroxetine (as hydrochloride or mesylate salt)
Form Tablets, Oral suspension
Pharmacological class Selective Serotonin Reuptake Inhibitor (SSRI)
Common use Modulating mood and reducing anxiety
Origin Synthetic (Chemically manufactured)

Seroxat: Definition and Classification as a Selective Serotonin Reuptake Inhibitor

Seroxat is a prescription-only, synthetic psychotropic agent classified within the pharmacological class of a Selective Serotonin Reuptake Inhibitor (SSRI). The active substance driving the therapeutic action is Paroxetine, typically supplied as the salt Paroxetine hydrochloride or Paroxetine mesylate. This classification places Seroxat among the second-generation Antidepressants, a group designed specifically for modulating key monoamine neurotransmitters within the central nervous system. Its identity as a single-ingredient medicine means its therapeutic effect is solely attributable to the action of Paroxetine. The efficacy of this pharmacological class is clinically recognized for providing stability to patients experiencing difficulties with mood regulation, a principle supported by numerous pharmacological studies.

Composition, Forms, and General Therapeutic Purpose

The fundamental action of Seroxat is based on the potent inhibition of serotonin reuptake, a mechanism that supports the stability of brain chemistry. Paroxetine achieves this by ensuring the chemical messenger serotonin remains available for an extended period in the synaptic space. This mechanism provides the foundation for the drug’s general role in promoting sustained emotional stability, often used when an adult patient requires support for pervasive anxiety or persistent mood disturbance. Seroxat is formulated for oral and systemic administration, being supplied as various dosage forms including film-coated tablets, standard tablets, and an oral suspension. A differentiating factor of the Paroxetine drug entity is the availability of specific controlled-release formulations, which allow for a gradual delivery profile, offering an alternative to immediate-release forms. The oral route ensures the therapeutic action is systematically distributed throughout the central nervous system.

What side effects are possible with Seroxat?

Seroxat: Possible side effects and safety information

The safety profile of Seroxat (Paroxetine) is established through official classification by regulatory authorities and is summarized based on the System Organ Classes and documented frequency of adverse reactions. This information is classified to ensure a neutral, descriptive understanding of the medicine’s risks, without providing clinical advice.


Adverse Reaction Frequencies and System Classes

The official documentation categorizes adverse reactions based on their frequency of occurrence.

Frequency Classification Examples of Officially Documented Adverse Reactions (Select)
Very Common (ge 1/10) Nausea, Abnormal ejaculation (for males).
Common (1/100 to <1/10) Somnolence, Insomnia, Dizziness, Headache, Dry mouth, Constipation, Diarrhea, Asthenia, Sweating, Sexual dysfunction.
Rare (1/10,000 to <1/1,000) Hyponatraemia (low sodium levels), Seizures, Angle-closure glaucoma.

Adverse effects commonly involve the Nervous system disorders (e.g., somnolence, dizziness) and Gastrointestinal disorders (e.g., dry mouth, constipation). These effects are often noted as being more frequently observed at the start of treatment.


Serious Safety Considerations and Regulatory Constraints

Official labeling explicitly lists Serious Adverse Reactions, including the potential for Serotonin Syndrome, a serious condition associated with over-stimulation of serotonin pathways, and the risk of Severe Cutaneous Reactions (e.g., Stevens-Johnson Syndrome).

Population-Specific Safety Notes exist for older adults, who may be at an increased risk of developing Hyponatraemia. Furthermore, strict Contraindications are documented, prohibiting the use of Seroxat with Monoamine Oxidase Inhibitors (MAOIs) and Pimozide due to the potential for severe adverse outcomes. The use of Paroxetine also carries a regulatory Boxed Warning concerning Suicidal thoughts and behaviors, particularly in younger patients during the initial phase of therapy.

Overdose and Emergency Response

Overdose and When to Seek Help

Recognizing Seroxat (Paroxetine) Overdose

Symptoms reported in cases of Seroxat overdose primarily involve the cardiovascular and nervous systems, potentially including coma, seizures, fever, confusion, sweating, fast or irregular heartbeat (tachycardia), and severe muscle stiffness or twitching. Patients have generally recovered without serious issues, even at high doses, although the severity of an overdose can escalate, potentially leading to a loss of consciousness.

Overdose risk is significantly increased when Seroxat is taken with alcohol or other psychoactive medicines, which may worsen the toxic effects.

Serotonin Syndrome

An overdose can lead to Serotonin Syndrome, a serious condition characterized by a cluster of symptoms such as agitation, hallucinations, rapid heart rate, high body temperature, overactive reflexes (hyperreflexia), and lack of coordination.

Emergency Action Required

Immediate medical attention is necessary if an overdose is suspected. If the individual is experiencing severe symptoms—such as having a seizure, trouble breathing, loss of consciousness, or collapse—emergency services (e.g., 911 or the local emergency number) should be called immediately. If the individual is conscious and able, call a poison control helpline for instructions. Do not wait for symptoms to worsen before seeking help; early supportive treatment is vital for managing overdose and toxicity.

Therapeutic Uses of Seroxat

Seroxat is commonly used to help manage symptoms related to systemic imbalance and heightened physiological activity. It is applied across domains where additional symptomatic support is needed, often relevant in conditions where functional stability becomes affected. The medication is generally used to help address conditions such as Major Depressive Disorder (MDD), Panic Disorder, Generalized Anxiety Disorder (GAD), Obsessive-Compulsive Disorder (OCD), and Post-Traumatic Stress Disorder (PTSD).

The primary therapeutic support is aimed at easing the intensity of symptoms like persistent low mood, excessive worry, and recurrent intrusive thoughts. This supportive relief helps patients cope more steadily with difficult episodes, applied when symptoms create noticeable physiological strain. The medication is also utilized for specific cyclical and physical manifestations, including symptoms associated with acute or episodic changes in Premenstrual Dysphoric Disorder (PMDD) and disruptive vasomotor symptoms associated with menopause.

“It is considered relevant in contexts marked by increased discomfort or tension, helping to support emotional regulation during difficult episodes.”

Quick Fact: Relief for Key Symptom Clusters
Seroxat may assist with managing intense fear reactions and intrusive, repetitive thoughts, supporting the patient during episodes of heightened discomfort and assisting with maintaining functional stability.

Regulatory References

  1. NIH MedlinePlus Drug Information overview

Eligibility and Restrictions for Use

Who can and cannot use Seroxat?

The population eligibility for Seroxat (paroxetine) is strictly defined by regulatory authorities, outlining both approved use and absolute prohibitions.

Category Regulatory Status (Official Statement)
Populations Allowed Adult patients (18 years and older) for labeled indications. Use in older adults (ge 65 years) is permitted but requires a reduced initial dosage due to altered clearance.
Populations Contraindicated Patients taking Monoamine Oxidase Inhibitors (MAOIs), including linezolid or intravenous methylene blue, and patients taking pimozide or thioridazine.
Age-Group Restrictions Not Approved for use in pediatric patients (under 18 years old) for psychiatric conditions.
Organ/Functional Restrictions Patients with severe renal impairment (CrCl < 30 mL/min) or hepatic functional impairment must start with a reduced initial dosage.
Pregnancy Eligibility Use during pregnancy carries an increased risk of fetal harm (e.g., PPHN). One specific formulation is contraindicated in women who are or may become pregnant.
Lactation Eligibility Use in nursing mothers is subject to a decision that weighs the importance of the medicine to the mother against infant exposure.

Connection to the overall eligibility profile

Regulatory documents define who can and cannot use Seroxat by establishing clear absolute prohibitions (contraindications against specific co-administered drugs) and setting age limits (not approved for pediatric use). The profile also mandates initial dose adjustments for populations with reduced drug clearance, such as older adults and individuals with kidney or liver impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define specific drug and substance interactions for Paroxetine, categorized by their required restrictions and effect on systemic exposure. Co-administration is contraindicated with Monoamine Oxidase Inhibitors (MAOIs), including Linezolid and intravenous Methylene Blue, due to the documented risk of Serotonin Syndrome. A mandatory 14-day period must elapse when switching between Paroxetine and an MAOI.

Paroxetine is classified as a strong inhibitor of the Cytochrome P450 2D6 (CYP2D6) enzyme, which is a key pharmacokinetic interaction. This inhibition elevates the plasma concentrations of co-administered CYP2D6 substrates such as Desipramine and Atomoxetine. Furthermore, this inhibition is the basis for the contraindication with Thioridazine and Pimozide, as increased plasma levels risk QTc prolongation.

Pharmacodynamic interactions involve additive effects. Concomitant use with other serotonergic agents (e.g., Triptans, Lithium, Tramadol) increases the risk of Serotonin Syndrome. Co-administration with drugs affecting hemostasis, such as Warfarin or Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), is associated with an increased risk of bleeding. The medication Cimetidine is documented to increase Paroxetine plasma concentrations. For immediate-release formulations, food may increase the maximum plasma concentration ( C max); however, controlled-release forms are not affected.

Mechanism of Action

How Seroxat Works: Mechanism of Action

Seroxat (Paroxetine) functions as a selective serotonin reuptake inhibitor. Its immediate action is concentrated on the serotonin transporter (SERT) protein located on the presynaptic neuronal membrane. The drug binds to and blocks SERT, preventing the reabsorption of the neurotransmitter serotonin from the synaptic cleft. This inhibition results in an increase in the concentration of available serotonin outside the presynaptic neuron.

The elevated synaptic serotonin initiates a cascade of events in the brain's serotonergic pathways, leading to long-term neuroplastic adaptation. This process involves the desensitization and down-regulation of certain postsynaptic and presynaptic serotonin receptors. This sustained modulation of the central serotonin system results in altered physiological set-points for signal transmission. The long-term physiological consequence of this dual-action mechanism is the alteration of signal flow within pathways that modulate emotional processing and impulse control, modifying the activity patterns of targeted neural systems.

Dosage and Administration Information

How Seroxat is Used in Clinical Practice

Seroxat (paroxetine) is administered exclusively through the oral route, being available across several dosage forms, including immediate-release (IR) tablets, controlled-release (CR) tablets, and an oral suspension. The medication is taken once daily, and generally, the dose is ingested in the morning. Clinical protocols confirm that administration is permissible with or without food.

Dosing follows a standardized, gradual approach. Treatment is initiated with a low starting dose (e.g., 10 mg/day or 20 mg/day), which is then adjusted based on the specific condition and formulation. Dose adjustments, when required, must be made slowly, utilizing increments of 10 mg or 12.5 mg that occur no more frequently than one-week intervals. The standard maximum daily dose typically ranges from 40 mg up to 75 mg, depending on the formulation and the indication being addressed.


Specific Administration Conditions

Instruction Detail
Controlled-Release Form CR tablets must be swallowed whole and not chewed or crushed to ensure the integrity of the controlled-release mechanism.
Population Adjustment Lower initial and maximum doses are required for older adults (e.g., maximum of 40 mg/day IR) and for patients with severe renal or hepatic impairment.
Discontinuation Cessation of therapy requires a gradual tapering of the dose over a period of time to follow standard protocol.
Missed Dose If a scheduled dose is missed, the general guidance is to omit the missed dose and resume the usual regimen at the next scheduled time; a double dose should not be taken.

Recent Clinical Evidence

Overview of Clinical Research

Clinical trials have evaluated the effects of Seroxat (paroxetine) across its approved indications, including Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), Panic Disorder, and Social Anxiety Disorder. Studies primarily compare the drug to a placebo to assess changes in specific symptom severity scales, such as the Hamilton Anxiety Scale (HAM-A) and the Epworth Sleepiness Scale (ESS) in relevant populations.

Key Findings by Indication

  • Major Depressive Disorder: Research, including placebo-controlled trials, has suggested that the medication is associated with sustained symptom reduction. Efficacy in preventing relapse has been noted in studies extending up to six months of treatment.
  • Generalized Anxiety and Panic Disorder: Multiple short-term (8-12 week) and long-term (6-month) randomized, double-blind, placebo-controlled trials have demonstrated that Seroxat use was associated with greater reductions in core anxiety symptoms and prevention of symptom recurrence compared to placebo.

Long-Term Safety and Special Populations

Clinical data extending up to five years have been used to assess the long-term tolerability profile, showing an acceptable safety profile for maintenance treatment in adults. However, epidemiological studies have explored the impact of first-trimester exposure on pregnancy outcomes, specifically noting an increased association with cardiovascular malformations. Regulatory warnings also exist regarding an increased risk of suicidal thoughts and behaviors in young adults (under 25) and adolescents, a finding consistent with the broader class of SSRIs.

Frequently Asked Questions (FAQ)

Common questions about Seroxat (FAQ)


Q: Is Seroxat the same type of medicine as Prozac or Zoloft?

Seroxat (paroxetine) is classified as a Selective Serotonin Reuptake Inhibitor (SSRI). Other well-known medicines, such as fluoxetine (Prozac) and sertraline (Zoloft), also belong to the same SSRI class, indicating they are categorized together based on their primary action.


Q: Can Seroxat interact with alcohol?

Regulatory sources advise patients to avoid the use of alcohol while undergoing treatment with paroxetine. The combination has the potential to intensify side effects, such as drowsiness, and may affect concentration.


Q: Can Seroxat interact with common medications for allergies?

Some allergy medications, particularly certain older antihistamines, can increase side effects like dizziness, confusion, or drowsiness when combined with Seroxat. Official documents often note that caution is advised when taking paroxetine with medicines that affect the central nervous system.


Q: Is Seroxat described as having a long or short half-life compared to other SSRIs?

Official pharmacological data indicates that the mean elimination half-life of paroxetine is approximately 21 hours. This data is noted in the drug’s pharmacokinetic information.


Q: What kind of monitoring is typically required while taking Seroxat?

Official information states that patients should be monitored closely for clinical worsening and the emergence of certain symptoms, especially during the initial phase of treatment or following dose adjustments. Regulatory warnings specifically require monitoring for signs of conditions like Serotonin Syndrome and the risk of suicidal thoughts and behaviors.


Q: Is it true that Seroxat can make you feel sleepy?

Yes, official documentation lists somnolence, which refers to sleepiness or drowsiness, as a Common adverse reaction. This means it is an effect that occurs relatively frequently according to clinical data.


Q: Can Seroxat cause problems with sleep, like insomnia?

Insomnia, or difficulty sleeping, is listed as a Common adverse reaction in the official product information for Seroxat. This is one of the possible effects on sleep that patients may encounter.


Q: Are there any studies that have looked at the long-term effects of Seroxat?

Clinical trials and data extending up to five years have been used to assess the long-term tolerability profile of Seroxat for maintenance treatment in adults. These studies have been used to assess the long-term tolerability profile when the medicine is used for extended periods.


Q: Can Seroxat affect libido or sexual function?

Official information indicates that Seroxat can affect sexual function. Sexual dysfunction, including decreased libido and abnormal ejaculation, is listed as a Common or Very Common adverse reaction in regulatory documents.


Q: Is it common to have stomach issues, like nausea, when first starting Seroxat?

Nausea is listed as a Very Common adverse reaction in the official documentation, as it affects 1 in 10 patients or more, according to clinical data. Gastrointestinal issues are often noted as being more frequently observed during the initial period of treatment.


Q: Is it possible for Seroxat to cause headaches?

Yes, official regulatory documents list headache as a Common adverse reaction. This indicates that a noticeable percentage of patients in clinical trials experienced this effect.


Q: Does Seroxat have a warning about increasing the risk of suicidal thoughts?

Official labeling includes a Boxed Warning concerning an increased risk of suicidal thoughts and behaviors. This warning applies primarily to children, adolescents, and young adults (up to age 24) when starting the medicine or when the dosage is changed.


Q: Is it safe to take Seroxat if you have liver problems?

Official product information indicates that patients with severe hepatic (liver) impairment may require a dosage adjustment. Regulatory documents also include rare post-marketing reports of severe liver dysfunction, indicating that caution is noted for this patient population.


Q: Does Seroxat cause weight gain in most people?

Official regulatory documents list weight gain as a possible adverse reaction noted under metabolism and nutrition disorders. This means it is an effect that has been reported during treatment.


Q: How long does it usually take to feel a difference after starting Seroxat?

Studies indicate that the full therapeutic effect may take several weeks to develop. While the medicine is absorbed quickly, the assessment of its effect is determined over time as treatment continues.


Q: Are there any common foods or drinks that should be avoided while taking Seroxat?

Official information confirms that both the immediate-release and controlled-release formulations of Seroxat can be taken with or without food. Beyond advice concerning alcohol, core regulatory documents do not note specific common dietary restrictions.


Q: Is Seroxat considered a controlled substance or addictive?

Seroxat (paroxetine) is a Selective Serotonin Reuptake Inhibitor (SSRI). It is not listed as a controlled substance by the Drug Enforcement Administration (DEA) scheduling.


Q: What are the rules for driving or operating machinery while on Seroxat?

Regulatory warnings state that Seroxat may impair a person's ability to drive or operate hazardous machinery due to potential side effects like dizziness or drowsiness. Official guidance recommends understanding how the medicine affects an individual before engaging in activities that require full mental alertness.


Q: How long does Seroxat stay in your system after you stop taking it?

The mean elimination half-life of paroxetine is approximately 21 hours, as noted in the drug’s pharmacokinetic data.


Q: What should be done if someone experiences strange dreams or nightmares on Seroxat?

Official product information lists abnormal dreams as an uncommon side effect. Regulatory guidance states that adverse effects should be reported to a healthcare provider.


Q: Is it normal to feel a bit more anxious or jittery when first starting Seroxat?

Yes, official documentation lists anxiety, nervousness, and agitation as common adverse effects. These feelings are often reported by patients, particularly when they initially start taking the medicine or when their dose is adjusted.


Q: Does Seroxat affect blood pressure?

While uncommon, official information reports that some patients may experience adverse effects on blood pressure, such as hypertension (high blood pressure) or postural hypotension (a drop in blood pressure when standing up). Tachycardia, which is a fast heartbeat, is also noted as a possible side effect.


Q: What research exists regarding the use of Seroxat during breastfeeding?

Research suggests that the levels of paroxetine found in breastmilk are generally low. Authoritative medical databases suggest that monitoring the infant for potential effects, such as irritability, agitation, or poor weight gain, may be necessary.


Q: Does Seroxat typically need to be taken indefinitely?

Clinical trials have established that Seroxat is effective for both the initial, acute phase of treatment and for long-term maintenance therapy to prevent relapse. The duration of treatment is determined by a healthcare provider based on the condition being addressed and the patient's response to maintenance therapy.


Q: Does Seroxat affect how well you can concentrate?

The official labeling lists potential effects such as attention disturbances, somnolence (sleepiness), and dizziness as possible adverse reactions. These effects may, in some cases, impair a person's ability to concentrate.


Q: What happens if someone accidentally takes too much Seroxat?

Symptoms reported in cases of overdose typically include general effects like drowsiness, nausea, vomiting, dizziness, and sweating. Official guidance emphasizes that any suspected overdose requires immediate medical attention.


Q: Can Seroxat cause changes in appetite?

Official documentation lists a decreased appetite as a Common adverse reaction. This effect is included in the category of metabolism and nutrition disorders.


Q: Does Seroxat affect blood sugar levels?

Official warnings note that Seroxat can make it more difficult to keep blood sugar levels stable in patients who have diabetes. If a patient has diabetes, increased monitoring of blood sugar may be necessary during treatment.


Q: Is Seroxat sometimes used to treat OCD (Obsessive-Compulsive Disorder)?

Yes, Obsessive-Compulsive Disorder (OCD) is listed as an approved indication for paroxetine in official regulatory documents.

How should Seroxat be stored and disposed of?

How to Store and Dispose of Seroxat

Seroxat (paroxetine) must be stored under specific conditions to maintain its stability, as required by regulatory labeling. Storage temperature must not exceed 30^circC. The tablets must be protected from both light and moisture and should be kept in the original package.

Child Safety and Disposal

The medicine should be stored strictly out of the sight and reach of children. Disposal of unused or expired product must follow local requirements for pharmaceutical waste. It is mandatory not to throw the medicine away via wastewater or household waste, ensuring proper environmental handling of the product.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Seroxat found in:

A-Z Index: